Genomma Lab Internacional, S.A.B. de C.V.
OTC: GNMLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Juan Marco Sparvieri
- Employees
- 1,605
- Headquarters
- Mexico City, Mexico
- IPO year
- 2012
- Market cap
- $818.2M
- Website
- https://www.genommalab.com
Loading GNMLF…
Loading profile data…Frequently asked questions about GNMLF
What does Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) do?
Genomma Lab Internacional, S.A.B. de C.V., alongside its various operating units, specializes in the creation, promotion, and distribution of a wide array of over-the-counter (OTC) pharmaceutical goods and personal care items. Its operations span across Mexico and numerous international markets. The company's extensive product portfolio addresse...
Where does GNMLF trade?
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) trades on the Other OTC.
What sector is GNMLF in?
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Genomma Lab Internacional, S.A.B. de C.V.?
Juan Marco Sparvieri is the chief executive officer of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF).
Where is Genomma Lab Internacional, S.A.B. de C.V. headquartered?
Genomma Lab Internacional, S.A.B. de C.V. is headquartered in Mexico.
Does GNMLF pay a dividend?
Yes — Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) paid a trailing twelve-month dividend of USD 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GNMLF go public?
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) completed its initial public offering in 2012.